SELECTIVE AND NONSELECTIVE LOSS OF IMMUNOREGULATORY MOLECULES (HLA-A,B,C ANTIGENS AND LFA-3) IN TRANSITIONAL CELL-CARCINOMA

被引:41
作者
NOURI, AME [1 ]
SMITH, MEF [1 ]
CROSBY, D [1 ]
OLIVER, RTD [1 ]
机构
[1] IMPERIAL CANC RES FUND,DIRECTORS LAB,LONDON WC2,ENGLAND
关键词
D O I
10.1038/bjc.1990.338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of the major histocompatibility complex (MHC) class I and II antigens and lymphocyte function-associated antigen-3 (LFA-3) was investigated using immunohistochemical staining of bladder tissue sections from 18 patients with transitional cell carcinoma (TCC) and two normal bladder specimens. The expressions of HLA-A, B, C antigens varied greatly between different tumours. Complete loss was observed in one of 18 cases. Moderate to strong expression of HLA-A, B, C antigens was observed in 10 of 18 cases with the remaining seven cases showing either weak expression or expression on only a proportion of the tumour cells. Selective loss of HLA-Bw6 was seen in one of 18 cases. In many cases heterogenous and often focal expression of HLA-D products was seen. In one case tumour cells not expressing HLA-DR antigens were adjacent to strongly HLA-DR expressing non-neoplastic bladder epithelium, indicating a lack of inducible HLA-DR in the tumour cells. LFA-3 was undetectable in two of 18 cases with the remaining 16 cases showing moderate to strong expression of the molecule. These findings indicate that a substantial proportion of bladder tumours have one or more of a wide range of different alterations in the expressions of immunoregulatory molecules that could contribute to escape from immune surveillance. © Macmillan Press Ltd., 1990.
引用
收藏
页码:603 / 606
页数:4
相关论文
共 27 条
[1]   GENETIC-CONTROL OF HLA-A AND B-ANTIGENS IN SOMATIC-CELL HYBRIDS - REQUIREMENT FOR BETA-2 MICROGLOBULIN [J].
ARCEGOMEZ, B ;
JONES, EA ;
BARNSTABLE, CJ ;
SOLOMON, E ;
BODMER, WF .
TISSUE ANTIGENS, 1978, 11 (02) :96-112
[2]   MONOCLONAL-ANTIBODY TO HLA-A3 [J].
BERGER, AE ;
DAVIS, JE ;
CRESSWELL, P .
HYBRIDOMA, 1982, 1 (02) :87-90
[3]   MONOCLONAL ANTIBODIES FOR ANALYSIS OF THE HLA SYSTEM [J].
BRODSKY, FM ;
PARHAM, P ;
BARNSTABLE, CJ ;
CRUMPTON, MJ ;
BODMER, WF .
IMMUNOLOGICAL REVIEWS, 1979, 47 :3-61
[4]  
COHEN PJ, 1987, AM J PATHOL, V129, P208
[5]   VARIATION IN MHC ANTIGENIC PROFILES OF TUMOR-CELLS AND ITS BIOLOGICAL EFFECTS [J].
FESTENSTEIN, H ;
SCHMIDT, W .
IMMUNOLOGICAL REVIEWS, 1981, 60 :85-127
[6]   DISTRIBUTION OF HLA CLASS-1 ANTIGENS IN NORMAL HUMAN-TISSUE AND IN MAMMARY-CANCER [J].
FLEMING, KA ;
MCMICHAEL, A ;
MORTON, JA ;
WOODS, J ;
MCGEE, JO .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (07) :779-784
[7]  
GARDINER KA, 1985, BR J UROL, V58, P19
[8]   CYTOTOXIC LYMPHOCYTES-T RECOGNIZE A FRAGMENT OF INFLUENZA-VIRUS MATRIX PROTEIN IN ASSOCIATION WITH HLA-A2 [J].
GOTCH, F ;
ROTHBARD, J ;
HOWLAND, K ;
TOWNSEND, A ;
MCMICHAEL, A .
NATURE, 1987, 326 (6116) :881-881
[9]   DOWN-REGULATION OF CELL-ADHESION MOLECULES LFA-3 AND ICAM-1 IN EPSTEIN-BARR VIRUS-POSITIVE BURKITTS-LYMPHOMA UNDERLIES TUMOR-CELL ESCAPE FROM VIRUS-SPECIFIC T-CELL SURVEILLANCE [J].
GREGORY, CD ;
MURRAY, RJ ;
EDWARDS, CF ;
RICKINSON, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) :1811-1824
[10]   REJECTION OF TRANSPLANTABLE AKR LEUKEMIA-CELLS FOLLOWING MHC DNA-MEDIATED CELL-TRANSFORMATION [J].
HUI, K ;
GROSVELD, F ;
FESTENSTEIN, H .
NATURE, 1984, 311 (5988) :750-752